Congratulations to Dr Hua-liang JIANG, an Editorial Board member of Acta Pharmacologica Sinica, for his extraordinary career accomplishment!
It is time to celebrate!
We are very proud to announce that, since 2003, Dr Hua-liang JIANG have had 27 citations to his article, A 3D MODEL OF SARS_COV 3CL PROTEINASE AND ITS INHIBITORS DESIGN BY VIRTUAL SCREENING [by Bin XIONG, Chun-shan GUI , Xiao-ying XU, Cheng LUO, Jing CHEN, Hai-bin LUO, Li-li CHEN, Guo-wei LI, Tao SUN, Chang-ying YU, Li-duoYUE, Wen-hu DUAN, Jin-kang SHEN, Lei QIN, Tei-liu SHI, Yi-xue LI, Kai-xian CHEN, Xiao-min LUO, Xu SHEN, Jian-hua SHEN, Hua-liang JIANG. Acta Pharmacol Sin 2003, 24 (6): 497–504. Received 2003-05-16 Accepted 2003-05-18]. What's more, the number of citations of this article received has placed it in the top 1% within its field according to Essential Science Indication SM . His work is highly influential and is making a significant impact among his colleagues in his field of study.
It is worth pointing out that it were Dr Jiang HL et al who firstly constructed a three-dimensional model for the 3C like proteinase of SARS coronavirus and designed anti-SARS drugs by virtual screening. Based on the finding published in Acta Pharmacologica Sinica, Dr Jiang managed to find a new strategy to discover anti-SARS compounds from the existing drugs by combining computationally virtual screening with bioassay. His latest work has been accepted by Journal of Virology recently and will be published as a Spotlight Paper soon.